Sabra Health Care REIT (SBRA) Gains from Investment Securities (2016 - 2026)
Sabra Health Care REIT has reported Gains from Investment Securities over the past 15 years, most recently at $1.7 million for Q1 2026.
- For Q1 2026, Gains from Investment Securities fell 30.03% year-over-year to $1.7 million; the TTM value through Mar 2026 reached -$718000.0, down 111.33%, while the annual FY2025 figure was -$7000.0, 100.13% down from the prior year.
- Gains from Investment Securities for Q1 2026 was $1.7 million at Sabra Health Care REIT, up from -$5.9 million in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $57.8 million in Q4 2022 and troughed at -$5.9 million in Q4 2025.
- A 5-year average of $3.8 million and a median of $547000.0 in 2022 define the central range for Gains from Investment Securities.
- Biggest five-year swings in Gains from Investment Securities: skyrocketed 10520.96% in 2022 and later tumbled 7195.24% in 2024.
- Year by year, Gains from Investment Securities stood at $57.8 million in 2022, then plummeted by 102.31% to -$1.3 million in 2023, then surged by 227.01% to $1.7 million in 2024, then plummeted by 449.91% to -$5.9 million in 2025, then surged by 127.97% to $1.7 million in 2026.
- Business Quant data shows Gains from Investment Securities for SBRA at $1.7 million in Q1 2026, -$5.9 million in Q4 2025, and $5.9 million in Q3 2025.